跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Approved
STANDARD
AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Devatis Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cd6b3f41fb7e5853
Company
Devatis Pty Ltd
Type
Standard
Approval Details
Approval Id
cd6b3f41fb7e5853
Product Name
AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Artg Id
216347
Artg Name
AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Sponsor
Devatis Pty Ltd
Company Detail Path
/organization/devatis-pty-ltd
Artg Date
2014-12-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/e0afebe8dc1d64aac26b2995bb4b7649.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cd6b3f41fb7e5853
Type
Standard
Back to TGA Approvals